cyclohexanol has been researched along with Shock, Septic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Najjar, T; Ali, BA; Nazer, LH; Shankar, G | 1 |
De Freitas, LA; De Souza, VL; Pompeu, MM; Rao, VS; Santos, FA; Silva, RM; Teixeira, MJ; Tomé, AR | 1 |
2 other study(ies) available for cyclohexanol and Shock, Septic
Article | Year |
---|---|
Fatal agranulocytosis associated with psychotropic medication use.
Topics: Adult; Agranulocytosis; Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents; Blood Cell Count; Cyclohexanols; Depressive Disorder, Major; Dibenzothiazepines; Fatal Outcome; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lamotrigine; Mianserin; Mirtazapine; Multiple Organ Failure; Neutropenia; Orbital Cellulitis; Psychotic Disorders; Psychotropic Drugs; Quetiapine Fumarate; Recombinant Proteins; Shock, Septic; Triazines; Venlafaxine Hydrochloride | 2012 |
1,8-cineole protects against liver failure in an in-vivo murine model of endotoxemic shock.
Topics: Animals; Cyclohexanols; Disease Models, Animal; Eucalyptol; Galactosamine; Lipopolysaccharides; Liver Failure; Male; Menthol; Mice; Monoterpenes; Shock, Septic; Solvents; Terpenes; Transaminases; Tumor Necrosis Factor-alpha | 2001 |